Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Stephen Hoge was one of three kickers vying for the starting job at Kansas University. Hoge announced on Monday, August 18, that he has left the team. Stephen Hoge was one of three kickers vying ...
Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...
Stephen Hoge is one of three kickers vying for the starting job at Kansas University. Hoge is battling with fellow red-shirt freshman Jacob Branstetter and junior-college transfer Grady Fowler.
Despite a significant revenue decline, Moderna Inc (MRNA) focuses on strategic program prioritization and cost management to ...
Dr Stephen Hodge Dr Stephen Hodge is Chief Technology Officer at Versarien plc, an advanced engineering materials group. The company creates innovative engineering solutions for its clients in a ...
and that causes us to want to actually start to pace ourselves," Moderna President Stephen Hoge said. The company expects its shares to trade on the Nasdaq Global Market under the ticker symbol ...
Please be advised, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead. Thank you, Kevin. Good morning, everyone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results